Final ID: MDP450
Berry Auburn, Desouza Christopher, Ruzzene Samuel, Izaias Joao E., Holzer Joshua, Orozco-fersiva Nathalie, Stone Madeleine, Greiner Jared, Garcia Vinicius, Stauffer Brian
Aficamten is safe and effective in oHCM with comorbidities obesity, hypertension, and diabetes: a SEQUOIA-HCM sub-studyLee Matthew, Malik Fady, Kupfer Stuart, Wohltman Amy, Coats Caroline, Abraham Theodore, Claggett Brian, Maron Martin, Miao Zi, Meder Benjamin, Olivotto Iacopo, Heitner Stephen, Jacoby Daniel